The leading market experts have placed a mean price target of $128.14 on ABIOMED, Inc. (NASDAQ:ABMD) stock. This price level, which is estimated to be attained in one-year, indicates the mean of stock opinions given by the companies included in the First Call survey. The renowned research firms have predicted earnings of $0.30 a share for the upcoming quarter and $1.17 for the current fiscal.
The technical analysis of ABIOMED, Inc. plainly substantiates that the 50-day moving average of ABIOMED, Inc. is $119.26, and stock is trading $-1.42 points away or -1.19% from its 50-day moving average of $119.26. Further it is trading $15.64 or +15.30% away its 200-day moving average of $102.20. ABIOMED, Inc. (NASDAQ:ABMD) 52-week high is $124.72 and the 52-week low is $67.81.
This explains if the stock moves $-6.88, it will post a 52-week high. In event of +73.78% decline, a 52-week low will be hit.
Taking the valuation aspect to emphasize the valuation of ABIOMED, Inc., shareholders can apply financial tool known as price-to-earnings ratio. This financial ratio assesses stock’s valuation by considering the relative expense of the stock. Following this ratio, ABIOMED, Inc. (NASDAQ:ABMD) ratio came in at 125.36.
The stock last ended the trading session at $117.84 and registered a market cap of $5.04B. To appraise firm’s growth, the shareholders take help of the Price-to-Earnings-Growth ratio. When a stock has a higher PEG ratio, it is suggestive of lower stock appreciation in approaching sessions. A stock comes in the group of undervalued stocks when its PEG ratio falls in between 0 and 1. ABIOMED, Inc. (NASDAQ:ABMD) PEG ratio is at 3.65.
1 Chart Pattern Every Investor Should Know